Global Drug Phenotypic Screening Platform Market Research Report 2025

Publication ID:

PB504260270

Publication Date:

May 2, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Drug Phenotypic Screening Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Drug Phenotypic Screening Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug Phenotypic Screening Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drug Phenotypic Screening Platform in Pharmaceutical Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drug Phenotypic Screening Platform include Melior Discovery, Creative Biolabs, PerkinElmer, TargetMol, MIMETAS, Evotec, ThermoScientific, Eurofins Discovery, Horizon Discovery, Crown Bioscience, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Phenotypic Screening Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Phenotypic Screening Platform.
The Drug Phenotypic Screening Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Phenotypic Screening Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Phenotypic Screening Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Melior Discovery
Creative Biolabs
PerkinElmer
TargetMol
MIMETAS
Evotec
ThermoScientific
Eurofins Discovery
Horizon Discovery
Crown Bioscience
Pharmaron
HD Biosciences
Segment by Type
In Vivo Screening
In Vitro Screening
Segment by Application
Pharmaceutical Company
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Phenotypic Screening Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Phenotypic Screening Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vivo Screening
1.2.3 In Vitro Screening
1.3 Market by Application
1.3.1 Global Drug Phenotypic Screening Platform Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Phenotypic Screening Platform Market Perspective (2020-2031)
2.2 Global Drug Phenotypic Screening Platform Growth Trends by Region
2.2.1 Global Drug Phenotypic Screening Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Phenotypic Screening Platform Historic Market Size by Region (2020-2025)
2.2.3 Drug Phenotypic Screening Platform Forecasted Market Size by Region (2026-2031)
2.3 Drug Phenotypic Screening Platform Market Dynamics
2.3.1 Drug Phenotypic Screening Platform Industry Trends
2.3.2 Drug Phenotypic Screening Platform Market Drivers
2.3.3 Drug Phenotypic Screening Platform Market Challenges
2.3.4 Drug Phenotypic Screening Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Phenotypic Screening Platform Players by Revenue
3.1.1 Global Top Drug Phenotypic Screening Platform Players by Revenue (2020-2025)
3.1.2 Global Drug Phenotypic Screening Platform Revenue Market Share by Players (2020-2025)
3.2 Global Drug Phenotypic Screening Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Phenotypic Screening Platform Revenue
3.4 Global Drug Phenotypic Screening Platform Market Concentration Ratio
3.4.1 Global Drug Phenotypic Screening Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Phenotypic Screening Platform Revenue in 2024
3.5 Global Key Players of Drug Phenotypic Screening Platform Head office and Area Served
3.6 Global Key Players of Drug Phenotypic Screening Platform, Product and Application
3.7 Global Key Players of Drug Phenotypic Screening Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Phenotypic Screening Platform Breakdown Data by Type
4.1 Global Drug Phenotypic Screening Platform Historic Market Size by Type (2020-2025)
4.2 Global Drug Phenotypic Screening Platform Forecasted Market Size by Type (2026-2031)
5 Drug Phenotypic Screening Platform Breakdown Data by Application
5.1 Global Drug Phenotypic Screening Platform Historic Market Size by Application (2020-2025)
5.2 Global Drug Phenotypic Screening Platform Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Phenotypic Screening Platform Market Size (2020-2031)
6.2 North America Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
6.4 North America Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Phenotypic Screening Platform Market Size (2020-2031)
7.2 Europe Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
7.4 Europe Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Phenotypic Screening Platform Market Size (2020-2031)
8.2 Asia-Pacific Drug Phenotypic Screening Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Phenotypic Screening Platform Market Size (2020-2031)
9.2 Latin America Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
9.4 Latin America Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Phenotypic Screening Platform Market Size (2020-2031)
10.2 Middle East & Africa Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Melior Discovery
11.1.1 Melior Discovery Company Details
11.1.2 Melior Discovery Business Overview
11.1.3 Melior Discovery Drug Phenotypic Screening Platform Introduction
11.1.4 Melior Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.1.5 Melior Discovery Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Drug Phenotypic Screening Platform Introduction
11.2.4 Creative Biolabs Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Details
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Drug Phenotypic Screening Platform Introduction
11.3.4 PerkinElmer Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.3.5 PerkinElmer Recent Development
11.4 TargetMol
11.4.1 TargetMol Company Details
11.4.2 TargetMol Business Overview
11.4.3 TargetMol Drug Phenotypic Screening Platform Introduction
11.4.4 TargetMol Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.4.5 TargetMol Recent Development
11.5 MIMETAS
11.5.1 MIMETAS Company Details
11.5.2 MIMETAS Business Overview
11.5.3 MIMETAS Drug Phenotypic Screening Platform Introduction
11.5.4 MIMETAS Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.5.5 MIMETAS Recent Development
11.6 Evotec
11.6.1 Evotec Company Details
11.6.2 Evotec Business Overview
11.6.3 Evotec Drug Phenotypic Screening Platform Introduction
11.6.4 Evotec Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.6.5 Evotec Recent Development
11.7 ThermoScientific
11.7.1 ThermoScientific Company Details
11.7.2 ThermoScientific Business Overview
11.7.3 ThermoScientific Drug Phenotypic Screening Platform Introduction
11.7.4 ThermoScientific Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.7.5 ThermoScientific Recent Development
11.8 Eurofins Discovery
11.8.1 Eurofins Discovery Company Details
11.8.2 Eurofins Discovery Business Overview
11.8.3 Eurofins Discovery Drug Phenotypic Screening Platform Introduction
11.8.4 Eurofins Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.8.5 Eurofins Discovery Recent Development
11.9 Horizon Discovery
11.9.1 Horizon Discovery Company Details
11.9.2 Horizon Discovery Business Overview
11.9.3 Horizon Discovery Drug Phenotypic Screening Platform Introduction
11.9.4 Horizon Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.9.5 Horizon Discovery Recent Development
11.10 Crown Bioscience
11.10.1 Crown Bioscience Company Details
11.10.2 Crown Bioscience Business Overview
11.10.3 Crown Bioscience Drug Phenotypic Screening Platform Introduction
11.10.4 Crown Bioscience Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.10.5 Crown Bioscience Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Details
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron Drug Phenotypic Screening Platform Introduction
11.11.4 Pharmaron Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.11.5 Pharmaron Recent Development
11.12 HD Biosciences
11.12.1 HD Biosciences Company Details
11.12.2 HD Biosciences Business Overview
11.12.3 HD Biosciences Drug Phenotypic Screening Platform Introduction
11.12.4 HD Biosciences Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.12.5 HD Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Melior Discovery
Creative Biolabs
PerkinElmer
TargetMol
MIMETAS
Evotec
ThermoScientific
Eurofins Discovery
Horizon Discovery
Crown Bioscience
Pharmaron
HD Biosciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂